Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 13 recruiting now early-phase tilt small index

Pancreatic Cyst: early-phase trial registry

13 of 19 indexed Pancreatic Cyst trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #902 of 28,707 conditions by registered trial count.

19 US clinical trials · 13 currently recruiting · #902 of 28,707 conditions by registered trial count

Pancreatic Cyst: 19 US clinical trials tracked, 13 recruiting.

Pancreatic Cyst is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Orlando Health, running 2 of these trials.

Enrollment posture brief

Registry condition pancreatic-cyst

OPEN 13 | RECR 68% | LATE 1 | EARLY 2 | RANK #902 | SPON 2

Nearest open-share peer: Gestational Hypertension (68% recruiting · 19 trials)

Pancreatic Cyst (this)68%Amyotrophic Lateral Sclerosi52.6%Anesthesia, Local42.1%Alcohol Consumption36.8%Attention Deficit Hyperactiv26.3%
Open-enrollment share among volume-matched conditions near Pancreatic Cyst

Pancreatic Cyst lists 13 open slots (68% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pancreatic Cyst on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pancreatic Cyst is recruiting above its size-band peers.

    13 of 19 indexed trials (68.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Pancreatic Cyst trials is spread across many organizations.

    Orlando Health accounts for 2 of 19 trials (10.5%). 16 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pancreatic Cyst enrolment sits around 250 participants.

    Median target enrolment is 250 among the 19 trials that report a genuine target (sentinel values excluded). 7 of those (36.8%) plan for fewer than 100 participants.

  4. Pancreatic Cyst research leans observational.

    7 interventional and 12 observational studies make up this index (36.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 31

Open and recent trials

19 total, page 1 of 1

RECRUITING 4,000 participants

UCSF PANC Cyst Registry

University of California, San Francisco

NCT04291651

RECRUITING 1,368 participants

Pancreas Registry and High Risk Registry

Icahn School of Medicine at Mount Sinai

NCT02775461

RECRUITING 1,174 participants

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

H. Lee Moffitt Cancer Center and Research Institute

NCT04275557

RECRUITING 700 participants

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Memorial Sloan Kettering Cancer Center

NCT03334708

RECRUITING 500 participants

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions

Ohio State University Comprehensive Cancer Center

NCT03492151

RECRUITING 500 participants

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Stanford University

NCT03260842

RECRUITING 310 participants

Artificial Intelligence in Endoscopic Ultrasound

Orlando Health

NCT06564571

RECRUITING NA 300 participants

Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies

University of Colorado, Denver

NCT04404101

RECRUITING 250 participants

PROMs After Pancreatectomy

University of Arizona

NCT07173257

RECRUITING NA 140 participants

EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

Orlando Health

NCT06340620

RECRUITING 25 participants

Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms

Memorial Sloan Kettering Cancer Center

NCT06305728

RECRUITING Phase 1 20 participants

Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection

M.D. Anderson Cancer Center

NCT05873699

RECRUITING Phase 1 15 participants

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

University of Nebraska

NCT06320990

ACTIVE NOT RECRUITING 317 participants

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

H. Lee Moffitt Cancer Center and Research Institute

NCT05692596

ACTIVE NOT RECRUITING 100 participants

Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry

The University of Texas Health Science Center, Houston

NCT07136324

ACTIVE NOT RECRUITING Phase 3 75 participants

CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Milton S. Hershey Medical Center

NCT03085004

COMPLETED 40 participants

Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract

Mauna Kea Technologies

NCT01770405

COMPLETED NA 37 participants

Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts

Ochsner Health System

NCT03169842

COMPLETED NA 33 participants

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

Indiana University

NCT01643460

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 1

Named interventions

Most-linked intervention names on Pancreatic Cyst records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Data collection Other
2 trials
98% Ethanol & Paclitaxel injection Procedure
1 trials
pancreatic cyst fluid glucose analysis using a bedside glucometer Device
1 trials
Endoscopic ultrasound fine needle aspiration Device
1 trials
Paclitaxel + Gemcitabine admixture Drug
1 trials
EUS-guided RFA treatment Device
1 trials
Bio-Specimen Collection Diagnostic test
1 trials
Hyperpolarized 13-C-pyruvate Drug
1 trials

US sites by state

Facility locations filed on Pancreatic Cyst trials. A trial with sites in several states counts in each.

New York 5 trials
Texas 4 trials
Florida 4 trials
California 4 trials
Indiana 3 trials
Pennsylvania 2 trials
New Jersey 2 trials
Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pancreatic Cyst page

19 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 13 Pancreatic Cyst trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Orlando Health sponsors the most Pancreatic Cyst trials on record, review their full trial history before evaluating a specific study. See Orlando Health's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pancreatic Cyst condition card totals 19 registered trials; most-linked intervention Data collection; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.